Pacer Advisors
KYNB

Pacer Advisors’s Kyntra Bio KYNB Stock Holding History

Pacer Advisors’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-88
Closed -$77K – 1456
2021
Q1 		$77K Sell
88
-41
-32% -$43.7K ﹤0.01% 1331
2020
Q4 		$120K Buy
129
+19
+17% +$20K ﹤0.01% 1335
2020
Q3 		$113K Buy
+110
New +$118K ﹤0.01% 1241
2018
Q4 		– Sell
-162
Closed -$246K – 723
2018
Q3 		$246K Buy
+162
New +$249K 0.01% 988
2018
Q1 		– Sell
-38
Closed -$45K – 1069
2017
Q4 		$45K Sell
38
-436
-92% -$547K ﹤0.01% 1028
2017
Q3 		$638K Buy
+474
New +$499K 0.06% 536

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pacer Advisors's KYNB Position: Q2 2021 in Review

Pacer Advisors sold out of Kyntra Bio (KYNB) in Q2 2021, closing a stake of 88 shares — an estimated $77K sold.

Pacer Advisors first reported a position in KYNB in Q3 2017 and held it in 6 quarters. The position peaked at $638K in Q3 2017. 174 funds tracked by Wall St. Rank hold KYNB as of Q2 2021.

  • Pacer Advisors reported no remaining Kyntra Bio position as of Q2 2021 after selling out during the quarter.
  • Pacer Advisors sold 88 Kyntra Bio shares in Q2 2021, an estimated $77K.
  • Pacer Advisors first reported a position in Kyntra Bio in Q3 2017 and held it in 6 quarters.
  • Pacer Advisors's Kyntra Bio position peaked at $638K in Q3 2017.
  • 174 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2021.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.